← Back
Data updated: Jun 28, 2026
STRIDES ARCOLAB LTD
Pharma Pharmaceuticals
STRIDES ARCOLAB LTD is a pharmaceutical company with 4 FDA-approved products.
-
Since
4
Drugs
-
Trials
0
New Drugs (2yr)
STRIDES ARCOLAB LTD's Key Drugs
STRIDES ARCOLAB LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
STRIDES ARCOLAB LTD's Recent FDA Approvals
New NDA/BLA approvals for STRIDES ARCOLAB LTD over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
STRIDES ARCOLAB LTD's Therapeutic Areas
Disease areas where STRIDES ARCOLAB LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
STRIDES ARCOLAB LTD Pipeline Snapshot
Active clinical trials for STRIDES ARCOLAB LTD across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 5
FDA Sponsor Names
STRIDES ARCOLAB LTDSTRIDES ARCOLAB